Company: CERO
Filing Date: 2025-11-20
Form Type: 424B3
Source: 0001213900-25-113118
Chunk: 38

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-20
Form: 424B3
Chunk 38
---
 | 978,809 |   |
| Less: imputed interest   |     |   | (47,786 | ) |
| Total lease liabilities  |     | $ | 931,023 |   |

NOTE 8 – STOCKHOLDERS’ DEFICIT

Successor Series A Convertible Preferred Stock

The Company designated 12,580
shares of its authorized preferred stock as the Series A Preferred Stock and the rights, preferences and privileges of the Series A Preferred
Stock are summarized below.

Each share of Series A Preferred
Stock has a stated value of $1,000 per share and, when issued, the Series A Preferred Stock was fully paid and non-assessable. The Series
A Preferred Stock, ranks senior to all other Company capital stock unless required holder votes are obtained to create a class of stock
senior to Series A Preferred Stock. The requisite holders of Series A Preferred Stock consented to the issuance of the Series C Preferred
Stock and Series D Preferred Stock, each as described below, which ranks senior to the Series A Preferred Stock and Series B Preferred
Stock.

Dividend and Participation Rights: The holders of Series A Preferred Stock will be entitled to dividends, on an as-if converted basis, equal to and in the same
form as dividends actually paid on shares of Common Stock, when and if actually paid. Series A Preferred Stockholders will be entitled
to participate pro rata in any purchase rights extended to holders of Common Stock on an as-converted basis.

Conversion: Each holder
of Series A Preferred Stock may convert at any time, all, or any part, of the outstanding Series A Preferred Stock into shares of the
Common Stock at the initial “Conversion Price” of $20,000, which is subject to customary adjustments for stock splits. The
Company’s Board of Directors has the right, at any time, with the written consent of the Required Holders (as defined in the Certificate
of Designation of Preferences, Rights and Limitations of the Series A Convertible Preferred Stock (the “Series A Certificate of
Designations”), to lower the fixed conversion price to any amount and for any period of time. If 90 days or 180 days following the
occurrence of the effective date of the registration statement filed pursuant to the First PIPE Registration Rights Agreement, the Conversion
Price then in effect is greater than the greater of $2,000.00 and the Market Price (as defined in the Series A Certificate of Designations)
then in effect (the